New User? Click here to register

Thoughts on DESTINY-Breast04 for HER2-low metastatic breast cancer.

Text generated by AI based on an exclusive interview, revised and reviewed by

Dr Jean-Philippe MINART, Cannes, France

October 20, 2023

Joseph GLIGOROV
MD, PHD Medical Oncologist, Paris, France

Clinical AI Trials Update: Promising Screening Approaches
Lungile GABUZA
What is the role of interventional radiology in bones metastatis ?
Radiotherapy : ongoing Clinical Trials in Early-Stage Breast Cancer
Sithembile NGIDI
Molecular profiling of breast cancers.
Frédérique PENAULT-LLORCA
Pathologist, Clermont Ferrand, France
Biopsy in metastatic disease : how to chose the best target ?
Asiya Maheen KHAN
Radiologist, Abou Dhabi, UAE